SCHEMBL4432775

SCHEMBL4432775

O=C(O)CN(c1ccc2[nH]ccc2c1)S(=O)(=O)c1cc(Cl)cc(Br)c1

nearest known ligand 0.41

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.41
KEAP1 Q14145 10/20 0.40
NFE2L2 Q16236 10/20 0.40
ALDH1A1 P00352 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.37
PER2 O15055 1/20 0.37
CRY1 Q16526 1/20 0.37
CRY2 Q49AN0 1/20 0.37
CYP2A6 P11509 1/20 0.35
AHR P35869 1/20 0.35
NR4A2 P43354 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4427287 0.92 KEAP1 (0.43) TP53KEAP1NFE2L2ALDH1A1L3MBTL1
SCHEMBL2850695 0.92 TP53 (0.44) TP53KEAP1NFE2L2ALDH1A1L3MBTL1
SCHEMBL4438191 0.88 KEAP1 (0.47) TP53KEAP1NFE2L2PER2CRY1
SCHEMBL13389986 0.86 PER2 (0.35) TP53KEAP1NFE2L2ALDH1A1PER2
SCHEMBL7355234 0.81 TP53 (0.52) TP53KEAP1NFE2L2ALDH1A1L3MBTL1
SCHEMBL4433156 0.81 KEAP1 (0.52) TP53KEAP1NFE2L2PER2CRY1
SCHEMBL10317516 0.81 KEAP1 (0.48) TP53KEAP1NFE2L2ALDH1A1L3MBTL1
SCHEMBL13389979 0.78 PER2 (0.38) TP53KEAP1NFE2L2ALDH1A1PER2
SCHEMBL11948414 0.78 HCRTR2 (0.44) ALDH1A1PER2CRY1CRY2
SCHEMBL11948410 0.78 PER2 (0.38) TP53PER2CRY1CRY2AHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2121600-B1 SUBSTITUTED ARYLSULPHONYLGLYCINES, THE PREPARATION THEREOF AND THE USE THEREOF AS PHARMACEUTICAL COMPOSITIONS BOEHRINGER INGELHEIM INT (DE) 2012-07-18 EP disclosed
EP-2121600-A2 SUBSTITUTED ARYLSULPHONYLGLYCINES, THE PREPARATION THEREOF AND THE USE THEREOF AS PHARMACEUTICAL COMPOSITIONS Boehringer Ingelheim International GmbH (DE) 2009-11-25 EP disclosed
WO-2008099000-A2 SUBSTITUTED ARYLSULPHONYLGLYCINES, THE PREPARATION THEREOF AND THE USE THEREOF AS PHARMACEUTICAL COMPOSITIONS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-08-21 WO disclosed